Parkinson's Disease Trial, By Invitation NCT07569133 Sponsor: Ho-Won Lee Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, By Invitation

NCT07569133
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing and able to give written consent to participate
  • People aged between 40 and 90 years, male or female
  • People who have been diagnosed with Parkinson's disease and are also experiencing symptoms of depression
  • People whose Parkinson's disease is rated at stage 1, 2, or 3 on the Hoehn and Yahr scale, which measures how far the condition has progressed (confirm with trial site)
  • People who have been on a stable Parkinson's disease medication routine for at least 3 months before the screening visit, with no planned dose increases during the study
  • People who score 14 or above (mild depression) or 20 or above (moderate depression) on the BDI-II, which is a standard depression questionnaire (confirm with trial site)
  • People who can read and write Korean and are able to complete questionnaires on their own

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with a history of epilepsy
  • People whose Parkinson's disease was caused by a stroke or blood vessel disease in the brain, a brain infection, poisoning or toxic exposure, or a traumatic brain injury
  • People diagnosed with conditions related to but distinct from Parkinson's disease, such as multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, or dementia with Lewy bodies
  • People whose liver-related blood test results are significantly outside the normal range (confirm with trial site)
  • People who have been diagnosed with a psychiatric disorder
  • People who are unable to follow instructions or communicate
  • People who are pregnant, breastfeeding, or women who could potentially become pregnant
  • People who currently have a fever
  • People who have an artificial hip joint implant
  • People who have metal implants or devices near the head or the area where treatment would be applied, such as cochlear implants, implanted brain stimulators, or aneurysm clips or coils
  • People with heart disease, particularly those who have a pacemaker
  • People whose vision, even with glasses or contact lenses, falls below a certain level (confirm with trial site)
  • People who use a drug infusion pump or a hearing aid
  • People who are currently experiencing an acute (sudden or short-term) illness
  • People taking certain medications including tricyclic antidepressants, neuroleptics, or other medicines that may lower the threshold for seizures
  • People with a history of increased pressure inside the skull or a history of head trauma
  • People with visible wounds on the brain or neck area
  • People experiencing significant symptoms such as hallucinations, delusions, or mania, beyond depression
  • People with a history of schizophrenia, bipolar disorder, or substance abuse
  • People who are currently having thoughts of suicide, as measured by a specific item on the BDI-II questionnaire (confirm with trial site)
  • People who have had, or are planning to have, deep brain stimulation surgery or certain other brain surgeries such as pallidotomy or thalamotomy
  • People considered ineligible by the trial investigators for medical or safety reasons
  • People currently enrolled in another clinical trial, or who have used an investigational drug or device within the past 30 days or within 5 half-lives of such a substance before giving consent (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Ho-Won Lee
Registry
ClinicalTrials.gov
Start date
4 May 2026
Est. completion
23 October 2026

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Beck Depression Inventory-II (BDI-II); Neuropsychiatric Inventory (NPI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov